A new study found that two doses of China’s Sinovac COVID-19 vaccine didn’t generate appreciable numbers of antibodies against the new, highly infectious, omicron variant. The study tested the blood from 25 people who were fully vaccinated with Sinovac’s Coronavac. None of them “contain sufficient antibodies to neutralize the Omicron variant,” researchers at the Department…

A 24-year-old Chinese technician for the Foxconn Group at the Zhejiang Jiashan Science and Technology Park in eastern China died after receiving a third shot of the SinoVac COVID-19 vaccine last month. Relatives have said they suspect that the cause of his death was related to the vaccination. The technician surnamed Cheng graduated from Hunan…

A 24-year-old Chinese technician for the Foxconn Group at the Zhejiang Jiashan Science and Technology Park in eastern China died after receiving a third shot of the SinoVac COVID-19 vaccine last month. Relatives have said they suspect that the cause of his death was related to the vaccination. The technician surnamed Cheng graduated from Hunan…

Hong Kong has lowered the age limit for China’s Sinovac vaccine from 18 to 3 years old, as the regime in Beijing pursues a zero-COVID-19 policy and a broader vaccination campaign. “Adolescents aged 12 to 17 will be accorded priority to receive the [Sinovac-]CoronaVac vaccine, with a view to extending to children of a younger…

Children as young as 3 years old will now be receiving vaccine doses in China as the country battles what Beijing has described as “rapidly developing” local COVID-19 clusters. City and provincial authorities in at least seven provinces have issued notices in recent days requiring children between three and 11 years old to be inoculated,…

Australian universities are pressing the federal government to approve the two Chinese vaccines Sinovac and Sinopharm, after Australia’s drugs regulator, the Therapeutic Goods Administration (TGA), said that it would be advising the government on Chinese and Indian vaccines soon. The regulator has so far approved Pfizer, Johnson and Johnson, Moderna, and AstraZeneca. Citing the World…

The Brazilian health regulator suspended the use of over 12 million doses of Chinese-made vaccines on Sept. 4 over being produced in an unauthorized plant, according to an official statement. Authorities said the ban was “a precautionary measure” to prevent “possible imminent risk.” “The manufacturing unit … was not inspected and was not approved by…

SAO PAULO—Brazil’s federal health regulator Anvisa on Saturday suspended the use of over 12 million doses of a COVID-19 vaccine developed by China’s Sinovac Biotech Ltd. that were produced in an unauthorized plant, it said in a statement. Anvisa said it was alerted on Friday by Sao Paulo’s Butantan institute, a biomedical center that has…

Chile declared on Aug. 5 that it will administer booster vaccines to citizens who have received China’s Sinovac in order to raise immunity. The move comes after finding the initial doses lose some effectiveness after several months’ time. Chile is one of the Latin American countries that has done most of its vaccinations with China-made…

A new study by researchers in Hong Kong has found that recipients of BioNTech’s Comirnaty COVID-19 vaccine generate 10 times more antibodies than the Chinese CoronaVac vaccine made by Sinovac. The study reported that even after receiving their first BioNTech dose, recipients’ antibody levels were higher than those who had received two doses of Sinovac. The…